A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...
A unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary ...
DxNA’s primary focus is on bringing the benefits of infectious disease molecular testing to underserved community hospitals and clinics so that critical diagnostic information is more readily and ...
DxNA’s primary focus is on bringing the benefits of infectious disease molecular testing to underserved community hospitals and clinics so that critical diagnostic information is more readily and ...
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next ...
HelixBind's patent pending Pathogen Identification (PID) platform will provide rapid detection and unequivocal identification of bloodstream infections, direct from a whole blood specimen and ...
Founded in January 2011 in Basel, Hutman Diagnostics is an in vitro diagnostics product development company, specialized in DNA based applications for the infectious disease market. The ...
Hygiena delivers rapid microbial detection, monitoring, and identification solutions to a wide range of industries, including food and beverage, health care, hospitality, pharmaceuticals, and ...
The Karius test harnesses next-generation sequencing to detect fragments of cell-free DNA from bacteria, viruses, fungi and protozoa that may be circulating in a patient’s bloodstream
LexaGene is a biotechnology company developing a fully automated pathogen detection platform for use at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and ...
A clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, autoimmune disorders and infectious ...
Mobidiag is a biotechnology company specializing in developing and marketing novel, innovative solutions for molecular diagnostics of infectious diseases.
MOLECULAR is a CLIA and CAP accredited, state-of-the-art, esoteric laboratory. We specialize in high-complexity molecular testing with an extensive portfolio of services including infectious ...
Scientists at Rocky Mountain Laboratories conduct basic research on infectious disease. RML is part of the National Institute of Allergy and Infectious Disease with the US National Institutes of ...
Childhood Cancer Research, Child Health, Behavior and Development, Clinical and Translational Research, Developmental Biology and Regenerative Medicine, Global Infectious Disease Research, ...
SIGA Technologies, Inc. is a pharmaceutical company set up in 1995 that is now based in New York City. The company markets pharmaceutical solutions for smallpox, Ebola, dengue, Lassa fever, and ...
Microbial Source Tracking (MST) is a set of methods used to determine the host (different animals or Human) that contributes fecal pollution to a variety of water bodies. Fecal pollution is a ...
Spartan is bringing complete sample-to-result DNA testing systems to medicine. Spartan’s technology fully integrates DNA collection, extraction and analysis, with an intuitive interface that is ...
SpinDiag one will rapidly detect drug-resistant bacteria within 30 minutes directly from patient samples with an easy and routine-compatible workflow. This allows screening of patients during ...
Summit develops treatments for rare and infectious diseases. The target Duchenne muscular dystrophy, a fatal genetic muscle wasting disease, and the infectious disease caused by the bacteria C ...
IDRI performs research on tests for diagnosing disease, vaccines, and adjuvants, and screens drug candidates. The research is focused on pathogens that cause problems globally such as tuberculosis ...
Since its inception in 1969, USAMRIID has spearheaded research to develop medical solutionsÑvaccines, drugs, diagnostics, and informationÑto protect our military service members from biological ...
